M&A Deal Summary |
|
---|---|
Date | 2000-09-05 |
Target | Transfusion Technologies |
Sector | Medical Products |
Buyer(s) | Haemonetics |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1971 |
Sector | Medical Products |
Employees | 2,708 |
Revenue | 870M USD (2021) |
Haemonetics is a healthcare company dedicated to providing innovative blood management solutions for our customers. Company devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Haemonetics was founded in 1971 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 1 of 13 |
Sector (Medical Products) | 1 of 7 |
Type (Add-on Acquisition) | 1 of 12 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 1 of 11 |
Year (2000) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-06-08 |
Arryx
Chicago, Illinois, United States Arryx, Inc. is a tools and technology for manipulation and measurement on the micro and nano lengthscales. Arryx is a holographic laser steering at microscopic and nanoscopic levels to improve manufacturing and processing productivity and profitability in multiple markets that are dependent upon miniaturization. |
Buy | $26M |